Structural

Top Story

FDA approves next-generation MitraClip for mitral regurgitation

FDA approves next-generation MitraClip for mitral regurgitation
July 15, 2019
In the Journals

LAA closure may save costs vs. anticoagulation in AF

July 3, 2019
At 10 years, left atrial appendage closure with an FDA-approved device was associated with cost savings compared with anticoagulation in patients with nonvalvular atrial…
In the Journals

Number of industry payments to hospital lab directors suggests potential conflicts of interest

June 19, 2019
A significant number of cardiac catheterization and electrophysiology laboratory directors have notable financial relationships within the biomedical industry that could…
Meeting News

MitraClip confers mitral regurgitation reduction in two trials

June 10, 2019
Patients with HF and moderate to severe mitral regurgitation who underwent transcatheter mitral valve repair had a greater reduction of mitral regurgitation at 30 days…
More Headlines »
Video
Meeting News

VIDEO: 'Incredible amount of science' presented at ESC Congress

October 7, 2018
More »
In the Journals

TRI-REPAIR: Valve reconstruction improves 6-month outcomes for tricuspid regurgitation

April 17, 2019
The use of a transcatheter tricuspid valve reconstruction system in patients with symptomatic and moderate-to-severe…
More »